BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10966508)

  • 1. Effects of arsenic-, platinum-, and gold-containing drugs on the disposition of exogenous selenium in rats.
    Gregus Z; Gyurasics A; Csanaky I
    Toxicol Sci; 2000 Sep; 57(1):22-31. PubMed ID: 10966508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of selenium excretion in bile by sulfobromophthalein: elucidation of the mechanism.
    Gregus Z; Perjési P; Gyurasics A
    Biochem Pharmacol; 1998 Nov; 56(10):1391-402. PubMed ID: 9825739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of glutathione in the biliary excretion of the arsenical drugs trimelarsan and melarsoprol.
    Gregus Z; Gyurasics A
    Biochem Pharmacol; 2000 Jun; 59(11):1375-85. PubMed ID: 10751546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of methylmercury and organic acid mercurials on the disposition of exogenous selenium in rats.
    Gregus Z; Gyurasics A; Csanaky I; Pintér Z
    Toxicol Appl Pharmacol; 2001 Jul; 174(2):177-87. PubMed ID: 11446833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of glutathione and methylation in the biliary excretion of selenium. The paradoxical effect of sulfobromophthalein.
    Gyurasics A; Perjési P; Gregus Z
    Biochem Pharmacol; 1998 Nov; 56(10):1381-9. PubMed ID: 9825738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between selenium and group Va-metalloids (arsenic, antimony and bismuth) in the biliary excretion.
    Gregus Z; Gyurasics A; Koszorús L
    Environ Toxicol Pharmacol; 1998 Mar; 5(2):89-99. PubMed ID: 21781854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of selenite on the disposition of arsenate and arsenite in rats.
    Csanaky I; Gregus Z
    Toxicology; 2003 Apr; 186(1-2):33-50. PubMed ID: 12604169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability and metabolism of 77Se-methylseleninic acid compared simultaneously with those of three related selenocompounds.
    Suzuki KT; Ohta Y; Suzuki N
    Toxicol Appl Pharmacol; 2006 Nov; 217(1):51-62. PubMed ID: 16962623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of cisplatin nephrotoxicity by sodium selenite. Lack of interaction at the pharmacokinetic level of both compounds.
    Vermeulen NP; Baldew GS; Los G; McVie JG; De Goeij JJ
    Drug Metab Dispos; 1993; 21(1):30-6. PubMed ID: 8095223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous tracing of 76Se-selenite and 77Se-selenomethionine by absolute labeling and speciation.
    Suzuki KT; Somekawa L; Kurasaki K; Suzuki N
    Toxicol Appl Pharmacol; 2006 Nov; 217(1):43-50. PubMed ID: 16956638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon.
    Davis CD; Uthus EO; Finley JW
    J Nutr; 2000 Dec; 130(12):2903-9. PubMed ID: 11110844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and excretion of 74As and 75Se in rats after their simultaneous administration. The effect of arsenic, selenium and combined pretreatment.
    Cikrt M; Mravcová A; Malátová I; Bencko V
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(1):17-29. PubMed ID: 3397527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of platinum, arsenic and selenium of cancer patients from the Antofagasta region in Chile treated with platinum-based drugs.
    Román DA; Pizarro I; Rivera L; Torres C; Avila J; Cortés P; Gill M
    BMC Res Notes; 2012 Apr; 5():207. PubMed ID: 22546077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of metals in rats: a comparative study of fecal, urinary, and biliary excretion and tissue distribution of eighteen metals.
    Gregus Z; Klaassen CD
    Toxicol Appl Pharmacol; 1986 Aug; 85(1):24-38. PubMed ID: 3726885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of glutathione in reduction of arsenate and of gamma-glutamyltranspeptidase in disposition of arsenite in rats.
    Csanaky I; Gregus Z
    Toxicology; 2005 Feb; 207(1):91-104. PubMed ID: 15590125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic interrelationships between arsenic and selenium.
    Levander OA
    Environ Health Perspect; 1977 Aug; 19():159-64. PubMed ID: 332496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of selenium on biliary secretion of methyl mercury in rats.
    Urano T; Imura N; Naganuma A
    Biochem Biophys Res Commun; 1997 Oct; 239(3):862-7. PubMed ID: 9367860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of potential antidotes on the acute toxicity, tissue disposition and elimination of selenium in rats.
    Paul M; Mason R; Edwards R
    Res Commun Chem Pathol Pharmacol; 1989 Dec; 66(3):441-50. PubMed ID: 2609019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic transformation of methylseleninic acid through key selenium intermediate selenide.
    Suzuki KT; Kurasaki K; Ogawa S; Suzuki N
    Toxicol Appl Pharmacol; 2006 Sep; 215(2):189-97. PubMed ID: 16600319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of selenium and arsenic mutual protection in human HepG2 cells.
    Kaur G; Ponomarenko O; Zhou JR; Swanlund DP; Summers KL; Dolgova NV; Antipova O; Pickering IJ; George GN; Leslie EM
    Chem Biol Interact; 2020 Aug; 327():109162. PubMed ID: 32524993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.